5 Analysts Have This to Say About CME Gr
Portfolio Pulse from Benzinga Insights
In the last quarter, 5 analysts have provided ratings for CME Gr (NASDAQ:CME), with 2 being somewhat bullish, 2 indifferent, and 1 bearish. The company has an average 12-month price target of $199.8, a decrease of 1.74% from the previous average price target of $203.33.
June 28, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Analysts' ratings for CME Gr are mixed, with an average 12-month price target of $199.8, down 1.74% from the previous target.
The mixed analyst ratings indicate uncertainty about the company's future performance. The decrease in the average price target could potentially impact the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100